×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-III :
  • 21 June, 2020

  • 5 Min Read

Antibodies against coronavirus start to decrease in 2-3 months,

Antibodies against coronavirus start to decrease in 2-3 months, study finds

Context

  • A few countries, including the U.K., were toying with the idea of issuing some form of a certificate to people who have been infected with novel coronavirus and recovered subsequently, as such people were assumed to be resistant to reinfection.

Study reveals

  • Now, a study published in Nature Medicine suggests that antibodies formed against SARS-CoV-2 begin to decrease in number, just two-three months after infection.
  • “We observed that IgG levels and neutralizing antibodies in a high proportion of individuals who recovered from SARS-CoV-2 infection start to decrease within two-three months after infection,” Quan-Xin Long from Chongqing Medical University, Chongqing, China and others write.
  • In contrast, circulating antibodies against 2002-2003 SARS and MERS coronavirus were found to last more than one year.
  • In the case of the 2002 SARS, sustained IgG levels were seen for more than two years after infection, while antibody response lasted for nearly three years in the case of MERS.

Is re-infection possible?

  • This does not necessarily mean that people previously infected with SARS-CoV-2 can be reinfected soon after.
  • Even if the antibody level decreases, it might be protective.
  • A person with low antibody level can get reinfected but the viral load will be low, infectivity will be less and he/she may not progress to a diseased state.
  • Antibodies specific to a virus even when present in low levels will be protective against disease.
  • Besides inducing neutralising antibodies, novel coronavirus has also been found to induce cellular immunity.
  • As a result, the immune system’s T cells and B cells are elevated in an infected person. “Generally, when antibody levels are high, the T cells are low and vice versa,” says Dr. John.
  • When infected by a virus, non-specific immune responses in the form of macrophages, neutrophils and other cells tend to prevent the virus from causing symptoms.
  • Soon after, the body makes antibodies specific to the virus called the immunoglobulins — IgG and IgM, called the adaptive response.
  • In addition, cellular immunity kicks in when the body makes T cells that destroy cells that have been infected by the virus.
  • The combination of adaptive response and cellular immunity “may prevent progression to severe illness or re-infection by the same virus. This process is often measured by the presence of antibodies in the blood,” WHO says.
  • They found that asymptomatic people were eliciting a weaker immune response to the virus compared with those who developed symptoms.
  • As a result, 40% of asymptomatic individuals had antibody levels at undetectable levels compared with nearly 13% in the case of symptomatic individuals.
  • Nearly 80% of people infected with SARS-CoV-2 show no or very mild symptoms.

Implications

  • The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys.
  • These data might indicate the risks of using COVID-19 ‘immunity passports’ and support the prolongation of public health interventions, including social distancing, hygiene, isolation of high-risk groups and widespread testing.
  • Besides T cells, people infected with coronavirus also make memory B cells, which rapidly produce antibodies when required.
  • If they find the virus again, they remember and start to make antibodies very, very quickly.
  • Another paper published in Nature found that even when the antibodies were present at low levels, it was sufficient to neutralise the virus.
  • The authors say that “most convalescent plasmas obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity” yet antibodies with “potent antiviral activity” were found in all these individuals.

Source: TH


Paramyrothecium indicum- Fungus

Scientists recently discovered a new species of fungus in Kerala, named ‘Paramyrothecium indicum’. Paramyrothecium indicum It is a new species of phytopathogenic fungus. Phytopathogens are parasites surviving on a plant host.  Most of Paramyrothecium are phytopathogens. They are responsible for “

Gentoo penguin-Chilean Antarctica

Recently, a photographer has spotted an extremely rare all-white Gentoo penguin in Chilean Antarctica. Gentoo penguin It is exclusively found in the Southern Hemisphere between 45 and 65 degrees south latitude. Within this range, gentoos are found on the Antarctic Peninsula as well as many sub-Antarctic islands. One of the mo

Tibetan brown bear-SIKKIM

A rare and elusive bear, the Tibetan brown bear, has been recently sighted in Sikkim, making it the first confirmed record of the animal being sighted in India. Tibetan Brown Bear The Tibetan brown bear, also known as the Tibetan blue bear, is one of the rarest subspecies of bears in the world and is rarely sighted in th

Windfall tax – Petroleum

India cut its windfall tax on petroleum crude to 1,700 rupees ($20.53) a tonne from 2,300 rupees a tonne, according to a recent government notification. Windfall Tax It is a tax levied by governments against certain industries when economic conditions allow those industries to experience significantly above-average pr

Gut Microbiota and Human Health

Scientists are finding that the gut microbiota may be linked to heart health, some cancers, and even the colour of urine. Gut Microbiota The human gut microbiota refers to the trillions of microbes, such as bacteria, viruses, fungi, and parasites, that live in the human gut. Previously, people referred to the gut microbiota as

DNA

01 Feb,2024

Toppers

Search By Date

Post Feed

Newsletter Subscription
SMS Alerts

Important Links